Clinical Trials Logo

Clinical Trial Summary

This is a clinical study for health care product safety assessment. The research will be conducted with 40 subjects*, aged 18 to 70 years. The product will be applied on the right and/or left participant back for 3 consecutive weeks. After 10 days, will have another application of the same product, which will be removed in 24 hours. Medical evaluation will be available throughout the study to assess possible adverse events. The objective of the study is to observe the effects of the application of the product on the skin and prove the absence of photoallergy and phototoxicity. * 29 completed the trial


Clinical Trial Description

40 subjects, aged 18 to 70 years, phototypes II to III (according to Fitzpatrick classification). The patch test will be used to verify the absence of photoallergy and phototoxicity by the investigational products. The products will be applied twice a week for 3 consecutive weeks, as they are over semi-occlusive dressings. The product will remain in contact with the skin for 24 hours, after product removal the area will be irradiated with ultraviolet lamp A and B (UVA/UVB). Then, the procedure will be repeated after 10 days of wash out. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04250623
Study type Interventional
Source Herbarium Laboratorio Botanico Ltda
Contact
Status Completed
Phase N/A
Start date April 12, 2021
Completion date May 21, 2021

See also
  Status Clinical Trial Phase
Completed NCT04332445 - Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Phototoxicity. N/A
Completed NCT05508243 - Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization of Hyaluronic Nasal Spray N/A
Completed NCT05508230 - Evaluation of Cutaneous Acceptability and Perceived Effectiveness of a Nasal Spray (Health Care Products) N/A
Completed NCT04248556 - Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization N/A
Completed NCT03375957 - Sensitization Study of ATx201 in Healthy Volunteers Phase 1